Lucia Hans to Piperazines
This is a "connection" page, showing publications Lucia Hans has written about Piperazines.
Connection Strength
0,388
-
Compelling evidence for unconditional shift to dolutegravir. Lancet HIV. 2022 08; 9(8):e523-e524.
Score: 0,194
-
Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment. Pediatr Infect Dis J. 2022 10 01; 41(10):827-834.
Score: 0,194